Smad2在TGF-β1诱导的黄韧带肥厚中的作用
该研究从50例患者获取黄韧带样本,培养黄韧带细胞后用小干扰RNA敲低p-Smad2、3或4,检测TGF-β1及下游因子表达。结果显示敲低p-Smad2可显著降低TGF-β1蛋白表达,并影响TNF-α和NF-κB表达,提示Smad2在黄韧带肥厚病理过程中可能发挥重要作用。
要点
- 敲低p-Smad2可显著降低黄韧带细胞中TGF-β1蛋白表达。
- Smad2可影响TGF-β1信号通路下游事件。
- Smad2敲低还降低TNF-α和NF-κB表达。
核心结论
- Smad2在黄韧带肥厚的病理发展中可能发挥潜在作用。
- 敲低Smad2可经降低TGF-β1、TNF-α和NF-κB表达影响TGF-β1信号通路。
研究设计与样本
- 获取50例患者的黄韧带样本,培养黄韧带细胞(LFCs)。
- 将靶向人p-Smad2、3或4基因的小干扰RNA转染LFCs。
主要发现
- 黄韧带退变表现为弹性纤维排列紊乱增加及细胞外胶原沉积所致纤维化转化。
- 敲低p-Smad2较其他组显著降低LFCs中TGF-β1蛋白表达水平。
- ELISA提示Smad2蛋白表达水平可影响LFCs中TGF-β1信号通路的下游事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertrophy of the ligamentum flavum (LF) contributes to the development of spinal stenosis. Smad proteins can mediate the fibrogenesis activity through the transforming growth factor β1 (TGF-β1) pathway, but which Smad protein plays a more important role in the hypertrophy process of LF is unclear. METHODS: The LF samples were obtained from 50 patients. After the LF cells (LFCs) were cultured, small interfering ribonucleic acid (siRNA) that target human phosphorylated-Smad2, 3, or 4 (p-Smad2,3,4) genes was transfected into LFCs. Next, proteins from cells were extracted and the protein levels of Smad2, Smad3, and Smad4 were detected by Western blot. The messenger ribonucleic acid level of TGF-β1 was measured by real-time polymerase chain reaction (PCR). Furthermore, an enzyme-linked immunosorbent assay was performed to test the impact of Smad2 downstream of the TGF-β1 signaling pathway. RESULTS: Degeneration of the LF was characterized by an increase in disorganized elastic fibers and fibrotic transformation by extracellular collagen deposition. The gene expression analysis of fibrotic genes in LFCs showed that knockdown of phosphorylated-Smad2 by siRNA significantly reduced the protein expression level of TGF-β1 compared with other groups. The enzyme-linked immunosorbent assay suggested that the protein expression level of Smad2 can influence the downstream events of TGF-β1 signaling pathway in the LFCs. CONCLUSIONS: Our findings suggest that Smad2 plays a potential role in the pathologic development of hypertrophy of LF. We also found that Smad2 knockdown by Smad-siRNA can influence the TGF-β1 signaling pathway through decreasing expression of TGF-β1, tumor necrosis factor α, and nuclear factor κb.
引用
- Wang L, Chang M, Tian Y, et al. The Role of Smad2 in Transforming Growth Factor β1-Induced Hypertrophy of Ligamentum Flavum. World Neurosurg. 2021. PMID: 33831616. doi:10.1016/j.wneu.2021.03.147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。